Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Morton Neuroma Imaging

  • Author: Steven Needell, MD; Chief Editor: Felix S Chew, MD, MBA, MEd  more...
 
Updated: Apr 30, 2015
 

Overview

Morton neuroma, or interdigital neuroma, is a common condition that involves enlargement of the interdigital nerve of the foot. Morton neuroma most commonly affects the third intermetatarsal space, but it can also affect the second intermetatarsal space, although it does so less often. Lesions in the fourth and first interspaces are unusual.

See the images of Morton Neuroma below.

Morton neuroma. Longitudinal T1-weighted (left) an Morton neuroma. Longitudinal T1-weighted (left) and short-tau inversion recovery (right) magnetic resonance images reveal a low–signal-intensity mass between the third and fourth metatarsal heads. Note how the mass is inconspicuous on the latter image.
Morton neuroma. Transverse T1-weighted (top) and c Morton neuroma. Transverse T1-weighted (top) and contrast-enhanced fat-suppressed T1-weighted (bottom) MRIs show the bulbous morphology of the perineural mass with plantar extension. The administration of contrast material reveals enhancement of the lesion.
Rheumatoid nodules. T1-weighted (top) and short-ta Rheumatoid nodules. T1-weighted (top) and short-tau inversion recovery (bottom) MRIs reveal large masses at the second and third interspaces. The latter image shows high signal intensity, which is not a feature of Morton neuromas. The patient had known rheumatoid arthritis, and the signal-intensity characteristics of these lesions are consistent with the proliferative synovium seen in this condition.

The etiology remains controversial, and treatment varies among practitioners. Diagnosing the condition involves clinical judgment, and in difficult cases, imaging may be useful in determining the precise diagnosis.

Differential diagnosis

The differential diagnosis of Morton neuroma includes a stress fracture, a tendon sheath ganglion, a foreign-body reaction, a nerve-sheath tumor, strain of the plantar capsule, and capsulitis or bursitis at the level of the plantar metatarsal-phalangeal joint (MPJ).[1, 2] Occasionally, the diagnosis can be challenging because, in addition to inflammation of the capsule or bursa, inflammation of the adjacent nerve also may be present, causing the neuritic sensation of a Morton neuroma.

Peripheral neuropathy also can cause symptoms such as a burning or neuritic sensation, but these tend to occur throughout the toes and on both feet. Additional differential diagnoses with similar symptoms involve neoplasms and fibromas. Imaging studies, particularly MRIs, are a valuable tool in differentiating these conditions.

Preferred examination

Neuromas are a common ailment seen by foot and ankle specialists. The diagnosis is often straightforward because of the description of a sharp, shooting pain or numbness in the affected digits. However, because the patients' descriptions of the pain can vary or because the pain can be related to another ailment in the differential diagnosis, MRI has become a useful imaging tool in obtaining a precise diagnosis. Ultrasonography also is commonly used. It is more widely available and less costly than MRI. Despite these advantages, the operator-intensive aspects of sonography, as well as its steep learning curve, are limiting factors. Whether ultrasonography will eventually replace MRI as the primary imaging modality for this condition remains to be determined.

In a study of 37 patients (43 intermetatarsal spaces) with confirmed Morton neuroma, MRI or ultrasound was performed to complement clinical diagnosis. An MRI was performed in 41 cases and ultrasonography in 23 cases. Of the 41 MRIs performed, 34 were positive for Morton neuroma and 7 were negative. MRI sensitivity was 82.9% [95% confidence interval (CI): 0.679-0.929]. Of 23 ultrasounds performed, 13 were positive and 10 were negative. US sensitivity was 56.5% (95% CI: 0.345-0.768).[3]

Next

Imaging

Although a Morton neuroma can often be confidently diagnosed on the basis of the clinical findings alone, imaging is useful in the preoperative setting or in cases with atypical symptoms.[1] Morton neuromas have been imaged successfully by using MRI, CT scanning, and ultrasonography.[2, 4] MRI has been the preferred imaging modality for demonstrating Morton neuroma largely because of MRI's superior contrast resolution and reproducibility.[5, 6]

Ultrasonography

Ultrasonography has the advantage of being less expensive and more portable than MRI, but because of its high learning curve and dependence on the operator's skill, whether ultrasonography will replace MRI as the preferred imaging modality for this condition remains to be seen. Relatively few radiologists and technologists in the United States are experienced in using ultrasonography to diagnose Morton neuroma. The employment of ultrasonography in this diagnosis, although described in the literature, most commonly occurs in subspecialty academic settings and outside the United States.[7]

Morton neuroma was confirmed on ultrasonography at the site of clinical diagnosis in 98% of patients (53 out of 54 feet) in one study. In the study, the diagnostic accuracy of 7 clinical tests for Morton neuroma were compared with ultrasonography. The 7 tests and their results were as follows: thumb index finger squeeze (96% sensitivity, 96% accuracy), Mulder's click (61% sensitivity, 62% accuracy), foot squeeze (41% sensitivity, 41% accuracy), plantar percussion (37% sensitivity, 36% accuracy), dorsal percussion (33% sensitivity, 26% accuracy), and light touch and pin prick (26% sensitivity, 25% accuracy). The thumb index finger squeeze test was the most sensitive screening test for the clinical diagnosis of Morton neuroma.[8]

MRI

Not uncommonly, Morton neuromas are incidental findings on MRIs; they are detected best on short-axis (transverse) T1-weighted MRIs through the metatarsal heads. Morton neuroma is typically seen as a bulbous mass arising between the metatarsal heads. Because neuromas have a highly cellular and/or fibrous nature, lesions demonstrate low signal intensity on both T1- and T2-weighted images (see the images below). The lesions are highly vascular and are typically enhancing after the intravenous administration of a gadolinium-based contrast agent.[9] Contrast enhancement is best visualized on T1-weighted fat-saturated images.

Morton neuroma. Longitudinal T1-weighted (left) an Morton neuroma. Longitudinal T1-weighted (left) and short-tau inversion recovery (right) magnetic resonance images reveal a low–signal-intensity mass between the third and fourth metatarsal heads. Note how the mass is inconspicuous on the latter image.
Morton neuroma. Transverse T1-weighted (top) and c Morton neuroma. Transverse T1-weighted (top) and contrast-enhanced fat-suppressed T1-weighted (bottom) MRIs show the bulbous morphology of the perineural mass with plantar extension. The administration of contrast material reveals enhancement of the lesion.
Rheumatoid nodules. T1-weighted (top) and short-ta Rheumatoid nodules. T1-weighted (top) and short-tau inversion recovery (bottom) MRIs reveal large masses at the second and third interspaces. The latter image shows high signal intensity, which is not a feature of Morton neuromas. The patient had known rheumatoid arthritis, and the signal-intensity characteristics of these lesions are consistent with the proliferative synovium seen in this condition.

Gadolinium-based contrast agents have been linked to the development of nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy (NSF/NFD). For more information, see the eMedicine topic Nephrogenic Fibrosing Dermopathy. NSF/NFD has occurred in patients with moderate to end-stage renal disease after being given a gadolinium-based contrast agent to enhance MRI or magnetic resonance angiography scans.

NSF/NFD is a debilitating and sometimes fatal disease. Characteristics include red or dark patches on the skin; burning, itching, swelling, hardening, and tightening of the skin; yellow spots on the whites of the eyes; joint stiffness with trouble moving or straightening the arms, hands, legs, or feet; pain deep in the hip bones or ribs; and muscle weakness. For more information, see the FDA Public Health Advisory or Medscape.

Reliably differentiating Morton neuroma from a normal plantar nerve is difficult unless the lesion is 5 mm or larger.[10] An intermetatarsal space lesion that is bright on T2-weighted images is unlikely to represent a Morton neuroma. Lesions with hyperintense signal on T2-weighted images are more likely to represent a true neuroma, a synovial or rheumatoid nodule, or bursal fluid. The administration of contrast material assists in differentiating these entities because true neuromas are intensely enhancing, and bursal fluid is not enhancing.[9]

MRI findings in a suggested Morton neuroma effectively influence therapy. In one study, imaging findings changed the treatment plan in 57% of patients, with the withdrawal of the diagnosis in 28% and with changes in the location or number of detected neuromas in more than 33% of the feet of the remaining patients.[10] Interspace lesions with low intensity appear on imaging studies in asymptomatic patients.[1] Therefore, careful correlation with the clinical findings is essential prior to initiating therapy.

Previous
 
Contributor Information and Disclosures
Author

Steven Needell, MD Director of Musculoskeletal Imaging, Boca Radiology Group, PA, Boca Raton Regional Hospital

Steven Needell, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, Society of Skeletal Radiology, Radiological Society of North America

Disclosure: Nothing to disclose.

Coauthor(s)

Jonathan Cutler, DPM Consulting Staff, Western Communities Foot and Ankle Center

Disclosure: Nothing to disclose.

Specialty Editor Board

Bernard D Coombs, MB, ChB, PhD Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand

Disclosure: Nothing to disclose.

William R Reinus, MD, MBA, FACR Professor of Radiology, Temple University School of Medicine; Chief of Musculoskeletal and Trauma Radiology, Vice Chair, Department of Radiology, Temple University Hospital

William R Reinus, MD, MBA, FACR is a member of the following medical societies: Alpha Omega Alpha, Sigma Xi, American College of Radiology, American Roentgen Ray Society, Radiological Society of North America

Disclosure: Nothing to disclose.

Chief Editor

Felix S Chew, MD, MBA, MEd Professor, Department of Radiology, Vice Chairman for Academic Innovation, Section Head of Musculoskeletal Radiology, University of Washington School of Medicine

Felix S Chew, MD, MBA, MEd is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America

Disclosure: Nothing to disclose.

Additional Contributors

Michael A Bruno, MD, MS, FACR Professor of Radiology and Medicine, Pennsylvania State University College of Medicine; Director, Radiology Quality Management Services, The Penn State Milton S Hershey Medical Center

Michael A Bruno, MD, MS, FACR is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America, Society of Nuclear Medicine and Molecular Imaging, Society of Skeletal Radiology

Disclosure: Received royalty from Oxford Press for book author/editor & reviewer; Received royalty from Elsevier Press for book author / editor.

References
  1. Zanetti M, Strehle JK, Zollinger H, et al. Morton neuroma and fluid in the intermetatarsal bursae on MR images of 70 asymptomatic volunteers. Radiology. 1997 May. 203(2):516-20. [Medline].

  2. Quinn TJ, Jacobson JA, Craig JG, et al. Sonography of Morton's neuromas. AJR Am J Roentgenol. 2000 Jun. 174(6):1723-8. [Medline]. [Full Text].

  3. Torres-Claramunt R, Ginés A, Pidemunt G, Puig L, de Zabala S. MRI and ultrasonography in Morton's neuroma: Diagnostic accuracy and correlation. Indian J Orthop. 2012 May. 46(3):321-5. [Medline]. [Full Text].

  4. Turan I, Lindgren U, Sahlstedt T. Computed tomography for diagnosis of Morton's neuroma. J Foot Surg. 1991 May-Jun. 30(3):244-5. [Medline].

  5. Zanetti M, Weishaupt D. MR imaging of the forefoot: Morton neuroma and differential diagnoses. Semin Musculoskelet Radiol. 2005 Sep. 9(3):175-86. [Medline].

  6. Studler U, Mengiardi B, Bode B, Schöttle PB, Pfirrmann CW, Hodler J, et al. Fibrosis and adventitious bursae in plantar fat pad of forefoot: MR imaging findings in asymptomatic volunteers and MR imaging-histologic comparison. Radiology. 2008 Mar. 246(3):863-70. [Medline].

  7. Lee MJ, Kim S, Huh YM, Song HT, Lee SA, Lee JW, et al. Morton neuroma: evaluated with ultrasonography and MR imaging. Korean J Radiol. 2007 Mar-Apr. 8(2):148-55. [Medline].

  8. Mahadevan D, Venkatesan M, Bhatt R, Bhatia M. Diagnostic Accuracy of Clinical Tests for Morton's Neuroma Compared with Ultrasonography. J Foot Ankle Surg. 2014 Nov 26. [Medline].

  9. Unger HR Jr, Mattoso PQ, Drusen MJ, et al. Gadopentetate-enhanced magnetic resonance imaging with fat saturation in the evaluation of Morton's neuroma. J Foot Surg. 1992 May-Jun. 31(3):244-6. [Medline].

  10. Zanetti M, Strehle JK, Kundert HP, et al. Morton neuroma: effect of MR imaging findings on diagnostic thinking and therapeutic decisions. Radiology. 1999 Nov. 213(2):583-8. [Medline]. [Full Text].

 
Previous
Next
 
Morton neuroma. Longitudinal T1-weighted (left) and short-tau inversion recovery (right) magnetic resonance images reveal a low–signal-intensity mass between the third and fourth metatarsal heads. Note how the mass is inconspicuous on the latter image.
Morton neuroma. Transverse T1-weighted (top) and contrast-enhanced fat-suppressed T1-weighted (bottom) MRIs show the bulbous morphology of the perineural mass with plantar extension. The administration of contrast material reveals enhancement of the lesion.
Rheumatoid nodules. T1-weighted (top) and short-tau inversion recovery (bottom) MRIs reveal large masses at the second and third interspaces. The latter image shows high signal intensity, which is not a feature of Morton neuromas. The patient had known rheumatoid arthritis, and the signal-intensity characteristics of these lesions are consistent with the proliferative synovium seen in this condition.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.